Main Menu

Targeted Therapy Team

Professor Harrington’s Targeted Therapy Team aims to develop new cancer therapies that selectively target cancer cells. This is accomplished by assessing combinations of viral, drug and immune therapies with radiation as a means of boosting both direct cytotoxic and indirect immune-related effects against cancers.

Team leader

Professor Kevin Harrington

Professor Kevin Harrington

Professor of Biological Cancer Therapies

Professor Kevin Harrington is Joint Head of the Division of Radiotherapy and Imaging and studies the use of biologically targeted agents, in combination with treatments such as radiotherapy and chemotherapy, to target cancer cells selectively. He is a specialist in head and neck cancer and in melanoma, and a Fellow of the Royal College of Physicians and the Royal College of Radiologists.

ORCID 0000-0002-6014-348X

Team members

Dr Edward Armstrong

Clinical Research Fellow

Gabby Baker

Scientific Officer

Galabina Bozhanova

PhD Student

Dr Matthew Chiu

Clinical Research Fellow

Eva Crespo Rodriguez

Research Intern

Dr Emma Davies

Clinical Research Fellow

Dr Shane Foo

Higher Scientific Officer

Lorna Grove

Higher Scientific Officer

Dr Victoria Jennings

Post Doctoral Training Fellow

Joan Kyula

Higher Scientific Officer

Jen Lee

Higher Scientific Officer

David Mansfield

Higher Scientific Officer

Martin McLaughlin

Higher Scientific Officer

Miriam Melake

Scientific Officer

Dr Emmanuel Patin

Post Doctoral Training Fellow

Malin Pedersen

Staff Scientist

Victoria Roulstone

Higher Scientific Officer

Dr Joseph Ward

Clinical Research Fellow